复方樟柳碱注射液治疗缺血性视神经病变患者的临床疗效分析  

Clinical Analysis of Compound Camptothecin Injection in the Treatment of Patients with Ischemic Optic Neuropathy

作　　者：张春芳 Zhang Chunfang(Ophthalmology Department,Beijing Zhongguancun Hospital,Beijing 100190)

机构地区：[1]北京市中关村医院眼科,北京100190

出　　处：《科技与健康》2025年第1期48-51,共4页Technology and Health

摘　　要：探讨缺血性视神经病变患者使用复方樟柳碱注射液的治疗效果。回顾性选取北京市中关村医院2020年6月—2024年6月收治的62例缺血性视神经病变患者为研究对象,随机分为对照组(复方血栓通胶囊治疗)和观察组(在对照组的基础上加用复方樟柳碱注射液治疗),每组各31例,对比两组患者的治疗效果。结果显示,观察组患者视力改善、眼底症状消失和治疗时间均短于对照组,血液流变学指标水平和不良反应发生率均低于对照组,临床疗效优于对照组,差异具有统计学意义(P<0.05)。研究发现,临床中治疗眼底病患者时使用复方樟柳碱注射液能够显著改善患者的血液流变学指标,加快患者的恢复速度,具有较高临床疗效和治疗安全性。To explore the therapeutic eff ect of compound camptothecin injection on patients with ischemic optic neuropathy.A retrospective study was conducted on 62 patients with ischemic optic neuropathy admitted to Beijing Zhongguancun Hospital from June 2020 to June 2024.They were randomly divided into a control group(treated with compound Xueshuantong capsules)and an observation group(treated with compound camphorazine injection in addition to the control group),with 31 patients in each group.The treatment eff ects of the two groups were compared.The results showed that the observation group had shorter visual acuity improvement,disappearance of fundus symptoms,and treatment time compared to the control group.The level of hemorheological indicators and incidence of adverse reactions were lower than those of the control group,and the clinical effi cacy was better than that of the control group,with statistical signifi cance(P<0.05).Research has found that the use of compound camptothecin injection in the treatment of patients with retinal diseases can signifi cantly improve their hemorheological indicators,accelerate their recovery,and have high clinical effi cacy and treatment safety.

关 键 词：复方樟柳碱注射液 缺血性视神经病变 临床效果 

分 类 号：R774.6[医药卫生—眼科]